From vaccines to AI: New weapons in the fight against cancer
Could humanity finally be gaining the upper hand in our age-old fight against cancer?
Feb 2, 2023
0
22
Could humanity finally be gaining the upper hand in our age-old fight against cancer?
Feb 2, 2023
0
22
Videos appearing to show people experiencing severe side effects after allegedly receiving COVID-19 vaccines are making the rounds on social media as part of a renewed push from anti-vaccine movements to cast doubt on safety.
Jan 27, 2023
0
22
A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based ...
Jan 19, 2023
0
4
US biotech company Moderna on Tuesday announced positive interim trial results for its vaccine against respiratory syncytial virus (RSV) in adults over the age of 60.
Jan 17, 2023
0
20
For the 2021 to 2022 influenza season, influenza vaccines were 36 percent effective against influenza A(H3N2)-related illnesses, according to a study published online Dec. 12 in Clinical Infectious Diseases.
Jan 4, 2023
0
22
In a first-of-its-kind study, researchers at Tel Aviv University equipped close to 5,000 Israelis with smartwatches and monitored their physiological parameters over two years. Of those monitored, 2,038 received the booster ...
Dec 28, 2022
0
108
While the production of COVID vaccines could have been the "light at the end of the pandemic tunnel," this outcome was hampered at critical stages by vaccine hesitancy, defined by the World Health Organization (WHO) as "the ...
Dec 5, 2022
0
6
The effectiveness of COVID-19 vaccines in preventing death remains high in children and adolescents regardless of the predominant circulating variant, suggests a large study from Argentina published by The BMJ today.
Nov 30, 2022
2
25
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against reinfection, depending on the variant. A new study led by Katrine Finderup ...
Nov 22, 2022
0
41
A vaccine (DCVax-L), trialed at King's College Hospital and other centers around the world, using patients' immune cells to target brain cancer can extend survival by many months or, in some cases, years, the final unblinded ...
Nov 21, 2022
0
82